title: Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients?
abstract: HCC constitutes 25-30% of primary malignant liver tumors in children. Conventional surgical excision is not possible in more than 50% of patients. LTx has recently become an important therapeutic option for adults and children with primary liver tumors. The aim of this study was a retrospective analysis of the clinical and pathological data of children with HCC treated with LTx in relation to Milan criteria assessed at diagnosis and then immediately before transplantation, in comparison with a group of patients treated conventionally. Between 1990 and 2007 we have treated 21 children diagnosed with HCC. Patients were divided into two groups: group I, 10 children treated conventionally and group II, 11 children treated with LTx regardless of previous therapy. The outcome of our patients treated conventionally with resection and chemotherapy is very poor--the disease-free survival rate is 30%. In contrast, despite that only 3 children having fulfilled adult Milan criteria, early clinical results of LTx are much superior. Total hepatectomy followed by LTx is the main treatment option for the majority of children with HCC. Decisions on the type of surgical treatment is made individually, but very early in the course of treatment.
authors.affiliation: Departments of Pediatric Surgery and Organ Transplantation, Children's Memorial Health Institute, Warsaw, Poland. h.ismail@czd.pl
authors.forename: H
authors.initials: H
authors.lastname: Ismail
authors.forename: D
authors.initials: D
authors.lastname: Broniszczak
authors.forename: P
authors.initials: P
authors.lastname: Kaliciński
authors.forename: M
authors.initials: M
authors.lastname: Markiewicz-Kijewska
authors.forename: J
authors.initials: J
authors.lastname: Teisseyre
authors.forename: M
authors.initials: M
authors.lastname: Stefanowicz
authors.forename: M
authors.initials: M
authors.lastname: Szymczak
authors.forename: B
authors.initials: B
authors.lastname: Dembowska-Bagińska
authors.forename: P
authors.initials: P
authors.lastname: Kluge
authors.forename: D
authors.initials: D
authors.lastname: Perek
authors.forename: A
authors.initials: A
authors.lastname: Kościesza
authors.forename: E
authors.initials: E
authors.lastname: Dzik
authors.forename: A
authors.initials: A
authors.lastname: Lembas
authors.forename: M
authors.initials: M
authors.lastname: Teisserye
mesh_terms: D000293:Adolescent; D006528:Carcinoma, Hepatocellular / Q000601:surgery / Q000628:therapy*; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D006801:Humans; D008113:Liver Neoplasms / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation / Q000379:methods*; D008495:Medical Oncology / Q000379:methods; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D012189:Retrospective Studies; D012307:Risk Factors; D014057:Tomography, X-Ray Computed / Q000379:methods; D016896:Treatment Outcome